Verrica Pharmaceuticals Inc.

Nasdaq:VRCA

Pharmaceutical Preparations·WEST CHESTER, PA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/11/25	Q1 FY2025	→
11/4/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

56 shown

Filed	Type	Description
12/30/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/24/25	Agreement	Entry into a Material Definitive Agreement	→
7/30/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
7/23/25	Other	Material Modification to Rights of Security Holders	→
7/1/25	Agreement	Entry into a Material Definitive Agreement	→
6/12/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
12/23/25	424B3	424B3	→
12/15/25	S-3	S-3	→
5/13/25	S-8	S-8	→
4/22/25	ARS	ARS	→
3/11/25	S-3	S-3	→
12/9/24	S-8	S-8	→
↓

Filing History(511 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001229

—

10.4 KB

3/A

Feb 2, 2026

0002101167-26-000004

Nov 25, 2025

5.2 KB

SCHEDULE 13G/A

Jan 29, 2026

0001315863-26-000100

—

14.4 KB

Jan 26, 2026

0002101167-26-000002

Nov 25, 2025

7.1 KB

Dec 30, 2025

0001556327-25-000006

Dec 23, 2025

4.6 KB

SCHEDULE 13D/A

Dec 30, 2025

0000902664-25-005417

—

9.1 KB

Dec 30, 2025

0000902664-25-005416

Dec 26, 2025

10.7 KB

Dec 30, 2025

0000902664-25-005415

Dec 26, 2025

2.9 KB

8-K

Dec 30, 2025

0001193125-25-3358248-K

Dec 23, 2025

139.3 KB

EFFECT

Dec 23, 2025

9999999995-25-003919

—

1.7 KB

424B3

Dec 23, 2025

0001193125-25-330986424B3

—

160.5 KB

S-3

Dec 15, 2025

0001193125-25-319225S-3

—

360.5 KB

Dec 10, 2025

0001231919-25-000594

—

14.7 KB

SCHEDULE 13G

Dec 3, 2025

0001011438-25-000591

—

14.8 KB

SCHEDULE 13D/A

Nov 28, 2025

0001494695-25-000006

—

11.8 KB

Nov 25, 2025

0001579649-25-000004

Nov 25, 2025

7.3 KB

Nov 25, 2025

0001556327-25-000004

Nov 25, 2025

7.5 KB

Nov 25, 2025

0002046750-25-000004

Nov 25, 2025

7.6 KB

Nov 25, 2025

0002043558-25-000003

Nov 25, 2025

11.0 KB

Nov 25, 2025

0001494695-25-000004

Nov 25, 2025

17.0 KB

SCHEDULE 13D

Nov 24, 2025

0000902664-25-005145

—

24.7 KB

8-K

Nov 24, 2025

0001193125-25-2921558-K

Nov 23, 2025

1.1 MB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-005162

—

10.4 KB

10-Q

Nov 14, 2025

0001660334-25-00000610-Q

Sep 30, 2025

6.2 MB

8-K

Nov 14, 2025

0001193125-25-2830788-K

Nov 14, 2025

288.9 KB

25 filings shown

Filed	Form	Description
4/30/25	DEFR14A	DEFR14A	→
4/22/25	DEFA14A	DEFA14A	→
4/22/25	DEF 14A	DEF 14A	→
4/11/25	PRE 14A	PRE 14A	→
4/19/24	DEFA14A	DEFA14A	→
4/19/24	DEF 14A	DEF 14A	→
↓

Verrica Pharmaceuticals Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(511 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/2/26	3/A	3/A	→
1/26/26	3	3	→
12/30/25	4	4	→
12/30/25	3	3	→
12/30/25	3	3	→
11/25/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/30/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/23/25	EFFECT	EFFECT	→
12/10/25	D	D	→
12/3/25	SCHEDULE 13G	SCHEDULE 13G	→
↓